ANN ARBOR, Mich. – Biopharmaceutical company Lycera Corp. announced that Kathleen M. Metters, former senior vice president and head of worldwide basic research at Merck, has been named president and chief executive officer and a member of the board of directors.
Prior to joining Lycera,Metters spent more than 20 years at Merck where she held multiple leadership roles of increasing responsibility.
Metters brings to Lycera more than 25 years of pharmaceutical discovery and development experience.
"Kathleen’s global pharmaceutical industry experience and leadership capabilities will be critical as Lycera continues to grow and transitions into a clinical-stage company in 2012," said Jeffrey Leiden, managing director at Clarus Ventures and chairman of Lycera’s board of directors. "Her unique skill set and track record of accomplishment as a drug developer will be important in shaping and driving the company''s business strategy and long-term success."